On May 11, 2018, President Trump released the American Patients First Blueprint (the "Blueprint"), a plan to lower drug prices and reduce beneficiary out-of-pocket spending on drugs in the Medicare program. The Blueprint builds upon a trio of documents released earlier in 2018 by the White House and its advisors that together provide the framework for a multi-faceted approach that the administration believes can reduce spending on prescription drugs in the United States while continuing to encourage growth and innovation.
With the Blueprint, the Trump administration continues to build on its policy initiative to control drug prices. This Blueprint is structured more as a series of policy options and questions than a comprehensive set of specific proposals. The administration is focused on approaches to address drug prices that encourage competition, redirect some behavior in the current marketplace that the administration believes is undesirable, and lower the prices that Americans pay for drugs.